SUCOSTRIN Drug Patent Profile
Which patents cover Sucostrin, and when can generic versions of Sucostrin launch?
Sucostrin is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in SUCOSTRIN is succinylcholine chloride. There is one drug master file entry for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sucostrin
A generic version of SUCOSTRIN was approved as succinylcholine chloride by ZYDUS PHARMS on May 4th, 2018.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SUCOSTRIN?
- What are the global sales for SUCOSTRIN?
- What is Average Wholesale Price for SUCOSTRIN?
Summary for SUCOSTRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Patent Applications: | 1,526 |
| DailyMed Link: | SUCOSTRIN at DailyMed |
US Patents and Regulatory Information for SUCOSTRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | SUCOSTRIN | succinylcholine chloride | INJECTABLE;INJECTION | 008847-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | SUCOSTRIN | succinylcholine chloride | INJECTABLE;INJECTION | 008847-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
